UPDATED Jun 20, 2024
Companys with strong funding and high growth potential
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BOVN.F | kr4.70 | 0% | n/a | kr2.7b | kr12.58 | PS9.2x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
0RV2 | kr219.08 | -3.1% | -32.0% | kr19.1b | kr373.25 | PS75.6x | E50.9% | 0% | Pharmaceuticals & Biotech | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
0A8R | US$228.95 | 4.6% | 81.1% | US$43.2b | US$229.12 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | Pharmaceuticals & Biotech | ||
IVVD | US$1.31 | -22.9% | 23.6% | US$167.0m | US$9.23 | PB0.9x | E69.8% | n/a | Pharmaceuticals & Biotech | ||
0A8K | US$31.24 | 6.4% | 658.3% | US$8.4b | US$29.16 | PS29.1x | E45.9% | n/a | Pharmaceuticals & Biotech | ||
ARDX | US$5.89 | -9.2% | 60.1% | US$1.4b | US$13.83 | PS8.7x | E60.7% | n/a | Pharmaceuticals & Biotech | ||
BRCT.F | kr21.00 | 0% | -30.1% | kr19.1b | kr36.18 | PS74.8x | E50.9% | 0% | Pharmaceuticals & Biotech | ||
LEGN | US$40.80 | -6.6% | -45.6% | US$7.4b | US$82.82 | PS21.7x | E63.7% | n/a | Pharmaceuticals & Biotech | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.30 | -4.3% | -48.5% | US$208.1m | US$23.22 | PS4.2x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
IVBI.Y | HK$19.75 | 1.4% | n/a | HK$60.5b | HK$29.36 | PS9.1x | E50.8% | n/a | Pharmaceuticals & Biotech | ||
CLRB | US$2.80 | -16.7% | 44.3% | US$95.7m | US$15.25 | PB11x | E66.9% | n/a | Pharmaceuticals & Biotech | ||
SPRY | US$7.73 | -13.5% | 20.4% | US$782.9m | US$19.00 | PS74900x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
MGTX | US$4.31 | -6.5% | -37.3% | US$274.6m | US$21.20 | PS24.4x | E56.1% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$2.53 | -15.4% | -3.1% | US$133.8m | US$8.50 | PS1.6x | E48.3% | n/a | Pharmaceuticals & Biotech | ||
SLNO | US$40.79 | -9.4% | 758.7% | US$1.5b | US$67.29 | PB10.4x | E65.2% | n/a | Pharmaceuticals & Biotech | ||
MDGL | US$267.79 | -3.3% | 10.0% | US$5.9b | US$365.07 | PB6.7x | E64.3% | n/a | Pharmaceuticals & Biotech | ||
TVTX | US$6.95 | -4.0% | -57.7% | US$540.5m | US$14.86 | PS3.4x | E67.6% | n/a | Pharmaceuticals & Biotech | ||
ACAD | US$14.75 | -2.3% | -38.6% | US$2.5b | US$27.16 | PS3x | E41.8% | n/a | Pharmaceuticals & Biotech | ||
CSPH.F | HK$0.12 | 0% | n/a | HK$1.4b | n/a | PS2.8x | E98.1% | n/a | Pharmaceuticals & Biotech | ||
ALDX | US$3.40 | -12.0% | -56.2% | US$215.7m | US$9.25 | PB1.8x | E60.0% | n/a | Pharmaceuticals & Biotech | ||
0JDK | US$8.02 | -1.7% | 0.4% | US$2.2b | US$25.91 | PS1171.4x | E64.5% | n/a | Pharmaceuticals & Biotech |